One-Stop Radiotherapy

One-stop radiotherapy refers to an integrated care model that brings key radiotherapy services into a coordinated pathway, potentially combining consultation, imaging, simulation, treatment planning, delivery, supportive care, and follow-up. Its relevance is grounded in the clinical need to reduce handoffs, shorten avoidable delays, improve information continuity, and make complex cancer care easier for patients and professionals to navigate. Adoption depends on clinical governance, infrastructure, workforce capacity, reimbursement, and the safe integration of digital systems.

Radiotherapy is shifting toward more personalized, image-guided, and workflow-coordinated care. Advances in treatment planning, adaptive techniques, motion management, hypofractionation, and remote collaboration are increasing the importance of reliable data exchange across the patient pathway. One-stop models can support this shift by aligning diagnostic imaging, multidisciplinary review, treatment preparation, and patient education, while requiring robust scheduling, quality assurance, cybersecurity, and radiation-safety processes.

Artificial intelligence is being applied to image segmentation, treatment planning support, quality checks, workflow prioritization, documentation, and clinical decision support. These applications may reduce repetitive tasks and help identify inconsistencies, but they do not remove the need for clinician oversight, validation, explainability, bias monitoring, and accountability. In one-stop radiotherapy settings, the greatest practical value is likely to come from interoperable tools that connect imaging, oncology information systems, scheduling, and follow-up rather than from isolated algorithms.

North America generally benefits from advanced oncology infrastructure, established multidisciplinary practice, and broad access to digital health capabilities, although affordability, workforce distribution, and rural access remain important constraints. Europe combines strong clinical standards with differing reimbursement systems, procurement rules, and cross-border data requirements. Asia-Pacific contains highly capable urban centers alongside substantial access gaps across lower-resource and geographically dispersed settings. Latin America continues to face uneven equipment availability, referral delays, and financing pressures. The Middle East is investing in specialized healthcare capacity while managing workforce and integration challenges, and Africa requires approaches suited to limited infrastructure, late presentation, treatment interruptions, and uneven access to trained personnel.

ASEAN markets often require scalable, interoperable models that can serve both advanced metropolitan hospitals and resource-constrained settings. BRICS members present diverse health systems, substantial population needs, and significant differences in domestic manufacturing, access, and regulatory environments. The European Union emphasizes coordinated standards, data protection, and cross-border health considerations, while the G7 generally has stronger research, clinical governance, and digital infrastructure but still faces capacity and equity pressures. GCC systems are positioned to develop integrated specialist centers, with attention needed for workforce sustainability and referral coordination. NATO members span varied health systems, making common priorities such as resilience, cybersecurity, emergency preparedness, and interoperable information exchange particularly relevant.

Australia must address geographic dispersion and the continuity of care for rural and remote populations. Brazil and Mexico face regional disparities in oncology access and the need to strengthen referral and treatment continuity. Canada and the United States have sophisticated capabilities but must manage cost, workforce distribution, and access across urban and underserved communities. China and India are expanding oncology capacity while balancing scale, regional inequality, and standardization. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom bring mature clinical systems, with priorities including efficiency, workforce planning, data interoperability, and equitable access. Russia’s implementation environment is shaped by regional variation, infrastructure needs, and continuity across a large geography.

Industry leaders should begin with pathway mapping that identifies delays, duplicated work, and high-risk handoffs before selecting technology. Build interoperable architecture around shared clinical data, standardized interfaces, role-based access, and cybersecurity controls. Establish multidisciplinary governance for AI and automation, including prospective validation, human review, incident reporting, and periodic performance audits. Design services around patient travel, accessibility, language, informed consent, psychosocial support, and treatment adherence. Use phased implementation with measurable indicators such as time from referral to consultation, planning turnaround, treatment interruptions, unplanned visits, patient experience, safety events, and equity of access.

This executive summary uses a structured qualitative synthesis of established radiotherapy practice, oncology-care delivery principles, health-system conditions, digital-health governance, and publicly documented technology trends. The analysis compares implementation factors across the required regions, country groups, and countries, focusing on care integration, infrastructure, workforce, regulation, access, and artificial intelligence. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments. Findings should be validated against local clinical guidelines, regulatory requirements, reimbursement policies, and site-level operational data before investment or deployment decisions.

The central opportunity is not simply to place more services in one location, but to create a dependable pathway linking diagnosis, treatment preparation, delivery, supportive care, and follow-up. Success will depend on coordinated teams, interoperable systems, safe automation, resilient infrastructure, and explicit attention to access disparities. Leaders that combine patient-centered design with rigorous clinical governance can make one-stop radiotherapy more coherent, efficient, and adaptable across diverse health-system settings.